Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Key Documents

HKI6MAG-99K

Millipore

MILLIPLEX® Human Kidney Injury Magnetic Bead Panel 6 - Toxicity Multiplex Assay

The analytes available for this multiplex kit are: β-2-Microglobulin (β2M), Clusterin, Cystatin C, RBP4.

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Kod UNSPSC:
12161503
eCl@ss:
32161000
NACRES:
NA.84

Poziom jakości

reaktywność gatunkowa

human

producent / nazwa handlowa

Milliplex®

assay range

accuracy: 103-133%
intra-assay cv: <10
sensitivity: 0.10-3.42 ng/mL
(MinDC+2SD)

standard curve range: 0.05-50 ng/mL
(β-2-Microglobulin (β2M))

standard curve range: 0.10-100 ng/mL
(RBP4)

standard curve range: 0.59-600 ng/mL
(Cystatin C)

standard curve range: 2.93-3,000 ng/mL
(Clusterin)

metody

multiplexing: suitable

metoda wykrywania

fluorometric (Luminex xMAP)

Warunki transportu

wet ice

Opis ogólny

Maintenance of physiological balance in the body is attributed in part to normal kidney function. Altered kidney function due to injury, drug toxicity or kidney failure may be life threatening. Toxicity is the leading cause of drug failure, so research is expanding in search of more sensitive, rapid methods to determine organ-specific damage as quickly as possible. Traditionally, blood urea nitrogen (BUN) and serum creatinine tests have been used to determine drug-induced damage to the kidney. These tests only detect kidney damage after it begins and do not allow for the elucidation of where in the kidney the damage has occurred. Specificity and earlier detection of kidney injury is vital, and this area of research is expanding in search of more sensitive, rapid methods for determining the specific area of damage in kidney.

The MILLIPLEX® portfolio provides valuable research assays to investigate multiple biomarkers of kidney injury in human serum and plasma samples using the [Luminex® xMAP® instrument platform.

The MILLIPLEX® Human Kidney Injury Bead Panel 6 contains all the components necessary to measure the following four biomarkers in any combination using [Luminex® xMAP® technology: β-2-Microglobulin (β2M), Clusterin, Cystatin C, RBP4. The kit uses a 96-well format, contains a lyophilized standard cocktail, two quality controls and can measure up to 38 serum or plasma samples in duplicate.

Panel Type: Toxicity

Specyficzność

Cross Reactivty
There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes within a panel.

Zastosowanie

  • Analytes: β-2-Microglobulin (β2M), Clusterin, Cystatin C, RBP4
  • Recommended Sample type: serum and plasma
  • Recommended Sample dilution: 1:3,000 in kit Assay Buffer. Customers should determine the optimal dilution factor for their samples. Our recommendations are based on serum and plasma samples from normal subjects.
  • Assay Run Time: Overnight
  • Research Category: Toxicity

Cechy i korzyści

Design your multiplex kit by choosing available analytes within this panel.

Opakowanie

Everything you need in a single kit.

Przechowywanie i stabilność

Recommended storage for kit components is 2 - 8°C.

Inne uwagi

Please contact Technical Service for linearity of dilution.
Sensitivity: Please see kit protocol for individual assay sensitivities.

Informacje prawne

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Oświadczenie o zrzeczeniu się odpowiedzialności

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
This page may contain text that has been machine translated.

Hasło ostrzegawcze

Danger

Zwroty wskazujące rodzaj zagrożenia

Klasyfikacja zagrożeń

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

Organy docelowe

Respiratory Tract

Kod klasy składowania

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

R Mateo-Gallego et al.
Nutrition, metabolism, and cardiovascular diseases : NMCD, 28(2), 133-142 (2018-01-14)
High-protein (HP) diets have shown benefits in cardiometabolic markers such as insulin or triglycerides but the responsible mechanisms are not known. We aimed to assess the effect of three energy-restricted diets with different protein contents (20%, 27%, and 35%; ∼80%

Powiązane treści

Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.

Exploring genotoxicity and DNA damage through multiplexing with MILLIPLEX® multiplex genotoxicity assays using Luminex® xMAP® technology enables the high-throughput measurement of phosphorylation levels of multiple proteins simultaneously and reduces sample volume, time, and cost.

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej